Connectivity infrastructure-as-a-service provider Freshwave has brought nearly 50 outdoor small cell sites live for mobile operator (MNO) EE in the Square Mile of the City of London, expanding ...
Cells on the inner surface of the intestine are replaced every few days. But, how does this work? It was always assumed that cells leave the intestinal surface because excess cells are pushed out. In ...
A synthetic cell that can be activated by a magnetic field to release a medicine while deep in the body has been created by chemists at UCL (University College London) and the University of Oxford.
The Prisoner—also known as the Beheaded—from Dead Cells slashes into BlazBlue Entropy Effect today! This crossover introduces the Prisoner as a fully playable character alongside an exclusive ...
For those with severe food allergies, just one morsel of the wrong thing can lead to a life-threatening reaction. A new understanding of how this begins could lead to better treatments, a study claims ...
Food allergies affect more than half a billion people worldwide. In severe cases, even a small bite of the wrong food can trigger anaphylaxis - a rapid, body-wide allergic reaction that can cause ...
When injured, cells have well-regulated responses to promote healing. These include a long-studied self-destruction process that cleans up dead and damaged cells as well as a more recently identified ...
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, ...
Mast cell tumors (MCTs) are the most common skin neoplasms in dogs and exhibit highly variable biological behavior. Metastasis primarily affects the lymph nodes, though less frequently, MCTs can ...
Scientists have developed a groundbreaking cryo-optical microscopy technique that freezes living cells mid-action, capturing ultra-detailed snapshots of fast biological processes. By rapidly ...
Celldex Therapeutics Pulls Plug On Eosinophilic Esophagitis Investigational Drug As Data Falls Short
Barzolvolimab cut mast cells by -36 vs. -2.7 in placebo at 12 weeks. Despite cell depletion, no symptom or endoscopic improvement in eosinophilic esophagitis. Want to trade this news? Get access to ...
Celldex has stopped development of barzolvolimab in eosinophilic esophagitis (EoE) despite meeting its primary endpoint in a phase 2 trial. The biotech showed the candidate depletes mast cells in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback